What is the appropriate evaluation and management for a patient with kidney stones, normal serum calcium, elevated intact parathyroid hormone (PTH) of 88 pg/mL, low 25‑hydroxy vitamin D of 17 ng/mL, and high 24‑hour urinary calcium excretion of 357 mg?

Evaluation and Management of Kidney Stones with Elevated PTH, Low Vitamin D, and Hypercalciuria

This patient most likely has secondary hyperparathyroidism driven by vitamin D deficiency, and the first step is to correct the vitamin D deficiency with ergocalciferol 50,000 IU weekly for 8 weeks, then reassess PTH and calcium levels before considering primary hyperparathyroidism. 1, 2

Diagnostic Approach

Step 1: Confirm Secondary vs. Primary Hyperparathyroidism

The clinical picture suggests secondary hyperparathyroidism due to vitamin D deficiency rather than primary hyperparathyroidism (PHPT) because:

• Normal serum calcium (PHPT typically presents with hypercalcemia) 1
• Low vitamin D at 17 ng/mL (below the 20-30 ng/mL threshold) 3, 4
• Elevated PTH of 88 pg/mL is appropriate compensation for vitamin D deficiency 3

The French expert consensus emphasizes that PTH should be measured after correction of vitamin D deficiency to avoid misdiagnosis 1. The elevated 24-hour urine calcium (357 mg) is paradoxical but can occur with secondary hyperparathyroidism when PTH drives calcium mobilization despite low vitamin D 5, 6.

Step 2: Rule Out Other Causes of Secondary Hyperparathyroidism

Before treating, verify:

• Dietary calcium intake: Low calcium intake can drive PTH elevation even with normal vitamin D 6
• Medications: Thiazides, bisphosphonates, corticosteroids, lithium can affect calcium-PTH axis 1
• Renal function: Already normal based on your presentation
• Malabsorption: History of bariatric surgery, celiac disease, inflammatory bowel disease 5, 2

Treatment Protocol

Phase 1: Vitamin D Repletion (Weeks 0-8)

Prescribe ergocalciferol 50,000 IU once weekly for 8 weeks 2. This is the standard repletion dose for vitamin D deficiency and is effective in correcting deficiency in adults 2.

Monitor during treatment:

• Serum calcium monthly for first 3 months 3
• If calcium exceeds 10.2 mg/dL, discontinue vitamin D immediately 3
• If calcium remains normal, continue full 8-week course

Phase 2: Reassessment (Week 8-12)

Recheck labs 4-6 weeks after completing repletion:

• 25-hydroxyvitamin D (target >30 ng/mL) 3, 4
• Serum calcium (corrected total or ionized)
• Intact PTH
• 24-hour urine calcium

Expected outcomes if secondary hyperparathyroidism:

• PTH should normalize or significantly decrease 3, 6
• 24-hour urine calcium may decrease as PTH-driven bone resorption resolves
• Serum calcium remains normal

If PTH remains elevated (>65-70 pg/mL) with vitamin D >30 ng/mL:

• This suggests normocalcemic primary hyperparathyroidism 1, 7, 8
• Proceed to parathyroid imaging (ultrasound + sestamibi or 18F-Choline PET-CT) 1
• Consider parathyroidectomy, especially given kidney stones and hypercalciuria 1, 9

Management of Hypercalciuria and Kidney Stones

Immediate Stone Prevention Measures

While treating the underlying PTH abnormality, implement stone prevention strategies 10:

1. Fluid intake: Target urine volume ≥2.5 liters daily 10
2. Dietary sodium restriction: Limit to 2,300 mg (100 mEq) daily, as high sodium increases urinary calcium 10
3. Maintain dietary calcium: 1,000-1,200 mg daily from food sources (do NOT restrict calcium) 10
4. Avoid calcium supplements: These may increase stone risk unlike dietary calcium 10

Critical Pitfall to Avoid

Do NOT withhold vitamin D treatment due to fear of worsening hypercalciuria 11, 12. While vitamin D supplementation can increase urinary calcium, the increase is often related to dietary factors rather than the vitamin D itself 11. The benefits of correcting vitamin D deficiency and resolving secondary hyperparathyroidism outweigh the transient risk 12.

Long-term Maintenance

Once vitamin D is repleted and PTH normalizes:

• Maintenance vitamin D: 1,000-2,000 IU daily or 50,000 IU every 2 weeks 2
• Annual 25-hydroxyvitamin D monitoring 3
• Repeat 24-hour urine calcium 3-6 months after PTH normalization to assess stone risk
• Continue dietary modifications for stone prevention 10

If Normocalcemic Primary Hyperparathyroidism is Confirmed

Parathyroidectomy should be considered if 1, 9:

• Recurrent kidney stones (already present)
• Persistent hypercalciuria >300-400 mg/24 hours
• Evidence of bone disease on DEXA
• Age <50 years

Research shows that timely diagnosis and treatment of PHPT in stone formers significantly reduces time to definitive treatment and prevents recurrent stones 9. However, some patients with normocalcemic PHPT and stones may not see improvement in stone risk after parathyroidectomy 13, emphasizing the importance of continued dietary stone prevention measures.